| 17th May 2023 7:15 am |
EQS |
Hardman & Co Research on Shield Therapeutics (STX): Reassuring 1Q’23 Accrufer prescriptions |
| 16th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 12th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 11th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 10th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 9th May 2023 5:20 pm |
RNS |
Form 8 (OPD) - Shield Therapeutics plc |
| 9th May 2023 4:00 pm |
RNS |
Rule 2.9 Announcement and TVR Update |
| 9th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 9th May 2023 11:04 am |
GNW |
Form 8.3 - Shield Therapeutics plc |
| 5th May 2023 3:09 pm |
RNS |
Form 8 (DD) - Shield Therapeutics Plc |
| 5th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 5th May 2023 11:55 am |
RNS |
Form 8.3 - SHIELD THERAPEUTICS PLC |
| 4th May 2023 2:40 pm |
RNS |
AOP Loan Conversion and Mandatory Cash Offer |
| 27th Apr 2023 7:00 am |
RNS |
Business Update and Unaudited Results |
| 12th Apr 2023 7:00 am |
RNS |
Notice of Results |
| 5th Apr 2023 7:00 am |
RNS |
Appointment of Chief Commercial Officer |
| 31st Mar 2023 7:00 am |
RNS |
Block Listing 6 Monthly Return |
| 15th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |
| 28th Feb 2023 7:00 am |
RNS |
Total Voting Rights Update |
| 17th Feb 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
| 17th Feb 2023 11:00 am |
RNS |
Price Monitoring Extension |
| 9th Feb 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 9th Feb 2023 4:35 pm |
RNS |
Price Monitoring Extension |
| 9th Feb 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
| 9th Feb 2023 9:00 am |
RNS |
Price Monitoring Extension |
| 9th Feb 2023 7:00 am |
RNS |
Full Year Trading Update |
| 23rd Jan 2023 11:15 am |
EQS |
Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital |
| 13th Jan 2023 10:30 am |
RNS |
Holding(s) in Company |
| 13th Jan 2023 7:16 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitability |
| 12th Jan 2023 2:40 pm |
RNS |
Holding(s) in Company |
| 12th Jan 2023 2:15 pm |
RNS |
Holding(s) in Company |
| 9th Jan 2023 5:10 pm |
RNS |
Partial AOP Loan Conversion |
| 9th Jan 2023 3:56 pm |
RNS |
Holding(s) in Company |
| 9th Jan 2023 3:25 pm |
RNS |
Holding(s) in Company |
| 5th Jan 2023 3:45 pm |
RNS |
Result of General Meeting & Open Offer |
| 28th Dec 2022 7:00 am |
RNS |
Total Voting Rights Update |
| 28th Dec 2022 7:00 am |
RNS |
PDMR Transaction Notification |
| 16th Dec 2022 7:00 am |
RNS |
Publication of Circular &Notice of General Meeting |
| 13th Dec 2022 3:45 pm |
RNS |
Successful completion of US$18.5m Equity Fundraise |
| 13th Dec 2022 7:02 am |
RNS |
Investor presentation |
